TRENINDG | India's fiscal deficit at 86.5% full-year target in February-end 2024
JUST IN | Sam Bankman-Fried sentenced to 25 years in prison for FTX fraud
TRENDING | US economic growth for last quarter is revised up slightly to a healthy 3.4% annual rate
TRENDING | E-insurance to become mandatory from April 1 — what it means for policyholders
TRENINDG | India's fiscal deficit at 86.5% full-year target in February-end 2024
JUST IN | Sam Bankman-Fried sentenced to 25 years in prison for FTX fraud
TRENDING | US economic growth for last quarter is revised up slightly to a healthy 3.4% annual rate
TRENDING | E-insurance to become mandatory from April 1 — what it means for policyholders
TRENINDG | India's fiscal deficit at 86.5% full-year target in February-end 2024
Join Us
Language
English
हिन्दी
Latest news
Markets
Economy
Personal Finance
India
World
Special Coverage
World Cup 2023
G20 Coverage
Diwali 2023
Chandrayaan 3
Election 2023
Assembly Elections 2023
Election Analysis
Lok Sabha Election 2024
Upcoming Events
Engage with CNBC-TV18
Photos
Videos
Minis
Web Stories
Polls
Quiz
Healthcare
Politics
Travel
Education & Careers
Sports
Views
Auto
Entertainment
Technology
Startups
Lifestyle
Retail
Real Estate
Minis
India Business Leader Awards
Branded Content
The Growth Summit
Ceo awards
Accelerate Your Cloud Journey
Accelerating to a Connected Future
Financial Services Cloud Symposium
Crypto
Education Next
Ey Entrepreneur Of The Year
IRMA
Wizards of finance
The Thought League
Discover CNBCTV18
About
Contact
Advertise
Disclaimer
Terms of Use
Privacy Policy
Shows
Anchors
Polls
11:11 Newsletter
Life
Watch Live TV
Market
Personal Finance
Business
Economy
Featured
NextGen
LIVE TV
New
CNBC-TV18 Accelerate
New
AI Alliance Pune
New
Election Exchange
New
SME Champion Awards
New
Latest News
Live
Market Live
Nifty
Sensex
MCX
Home
Latest News
Featured
Live TV
CNBC-TV18
CNBC Awaaz
CNBC Bajar
Market Live
Minis
Podcasts
CNBC-TV18 Specials
Young Turks
Mind Matters
Climate Clock
Marquee Nights
Future Female Forward
11:11 Newsletter
Photos
Sections
Market
Global Markets
Stocks
Money
Companies
Economy
Technology
Cryptocurrency
Terms and Conditions
Disclaimer
Terms of Use
Privacy Policy
home
Biosimilars News
Biosimilars NEWS
All
News
Photo
Video
business | Mar 28, 2024 5:14 PM IST
Wockhardt to use QIP funds to pare debt
market | Feb 28, 2022 1:13 PM IST
Biocon-Viatris deal: Key highlights for investors from the analyst call
healthcare | Nov 25, 2021 10:10 AM IST
The Medicine Box: Life-saving drugs getting greater accessibility, reduced prices, says Kiran Mazumdar-Shaw
healthcare | Nov 18, 2021 10:05 AM IST
The Medicine Box: Vaccine industry to grow from $40 billion to over $75 billion by 2025, says Kearney's Saumya Krishna
healthcare | Nov 18, 2021 10:03 AM IST
The Medicine Box: Kearney's Saumya Krishna explains how 'Make In India' can fuel 4X growth in vaccines, biosimilars by 2026
earnings | Jul 23, 2021 3:47 PM IST
Maintain $1 billion revenue target for biosimilars biz, but won't achieve it in FY22: Biocon's Kiran Mazumdar Shaw
earnings | Jan 22, 2021 2:45 PM IST
Biocon: Many opportunities to unlock in EMs in biosimilars business, says Kiran Mazumdar Shaw
healthcare | Feb 11, 2020 1:15 PM IST
Crucial weeks ahead for Biocon amid growing competition in trastuzumab market, regulatory inspections
healthcare | Dec 3, 2019 9:59 AM IST
Launch of Trastuzumab in US market offers a sizeable opportunity for Biocon & Mylan, says Kiran Mazumdar Shaw
healthcare | Jul 30, 2019 8:57 AM IST
Pfizer-Mylan deal will not impact Biocon's business, says CMD Kiran Mazumdar Shaw
healthcare | May 15, 2019 11:13 AM IST
IPO of biologics division likely in next few years, says Biocon's Kiran Mazumdar Shaw
photos | May 3, 2019 2:38 PM IST
It's bull and bear case for Biocon: Analysts divided as flat performance of biologics business spooks market
healthcare | Apr 26, 2019 2:34 PM IST
Biocon sees strong growth for generics biz in US in FY20, expects rise in R&D spends
healthcare | Jan 25, 2019 4:14 PM IST
Biocon to raise capital through private equity or IPO, says chairperson Kiran Mazumdar Shaw
healthcare | Jan 2, 2019 9:29 AM IST
Why biosimilars are a huge opportunity for the Indian biopharmaceutical industry
Most Read
Share Market Live
View All
Top Gainers
Top Losers
Currency
Commodities
Currency
Price
Change
%Change